RNA 8-K/A 2026-10-09

Atrium Therapeutics, Inc. (RNA) 8-K/A dated 2026-10-09 — accession 0001193125-26-418417. This URL is the filing, not the RNA hub.

Atrium Therapeutics, Inc. (RNA) is a biotechnology company listed on NASDAQ.

Atrium Therapeutics, Inc. filed a 8-K/A on 2026-10-09. Accession 0001193125-26-418417.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RNA revenue for 2025-12-31 was $18.8M. Net income was -$684.6M. Revenue was up 72.1% from 2024-12-31 to 2025-12-31. RNA currently screens at market cap $217.5M.

Not investment advice. The RNA SEC hub lists recent forms. The stock page is the research view.